Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05348434
Other study ID # Tishreen U- Maxillofacial sur
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 25, 2020
Est. completion date April 10, 2022

Study information

Verified date April 2022
Source Tishreen University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Objective: Evaluation of using 3D printed polyether ether ketone facial implants in repairing maxillofacial deformities. Research materials and methods: The research sample consisted of 10 patients with facial deformities (maxillofacial trauma patients with hard tissue deficiencies, tumor patients who had previous facial surgery, patients have retrognathia, congenital malformation, patients with hemifacial microsomia - bone loss as a result of a mucormycotic infection or black fungus ) Between 2020 and 2021 in the Department of Oral and Maxillofacial Surgery in the Tishreen University Hospital - Latakia - Syria. All patients underwent Computed Tomography (CT) scans under the condition of providing a large number of slices (more than 200 slices) per axis, and the thickness of each slice is less than 1 mm with 64-bit resolution, Then the design of the required facial implant was carried out in coordination between the designer and the surgical team. The final form of the facial implant was printed from PolyEther Ether Ketone (PEEK), and then surgical work was performed for patients under general anaesthetic according to the appropriate surgical entrance. The implants were fixed in place using titanium screws and the patients were given appropriate pharmacological coverage .


Description:

10 patients with maxillofacial deformities (trauma patients, war injuries, patients with pre-existing maxillofacial tumours, and mucormycotic patients) for reconstruction with 3D printed facial implants made of PEEK, between 2020 and 2021 in the Department of Oral and maxillofacial Surgery at the Tishreen University Hospital, Latakia, Syria. All patients underwent three-axial CT scan using a Toshiba Slice CT Scanner-Imaging, under the condition of providing a large number of slices (more than 200 slices) per axis, and the thickness of each slice is less than 1 mm with 64-bit resolution. Representative models of patient anatomical data were created based on the radiated raw data of the patient obtained via Digital Imaging and Communications in Medicine (DICOM) from the CT scan. The DICOM format is 0.3 to 0.6 mm thick, depending on the anatomical region. The medical modelling software (EXoCad) was used to compile DICOM data at the axial, sagittal, and coronal planes and then create a 3D virtual model of the anatomical region. The surgeon and the manufacturing technician met to discuss the design format and any modifications required, with the proposed areas for placement of the titanium screws for the installation of the facial implant. The final default model for the facial implant was exported as a STereoLithography (STL) file and sent to the 3D printer, which was eventually made for the patient. The printer used in our study is a prototype of OO-Kuma Katana HT PEEK 3D Printer. After the process of printing, the facial implant is steam sterilized and then the implant is encapsulated. The surgical work of the patients was performed under general anaesthesia at the Tishreen University Hospital, Latakia, Syria, at the appropriate surgical entrance depending on the size and location of the deformity. The facial implant was checked to be suitable before stabilization and the required modifications were made during the process. The PSI was fixed in place using 1.5 to 2.0mm sized titanium screws, all patients received an intravenous 1.2g Augmentin dose and 0.5g of Flagyl during the procedure. After the surgery, patients received two doses of Augmentin, after which a prescription of Augmentin 1g and Flagyl 0.5g orally per day for a week was given.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date April 10, 2022
Est. primary completion date March 5, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - patients with facial deformities: 1. maxillofacial trauma patients with hard tissue deficiencies 2. tumor patients who had previous facial surgery 3. patients have retrognathia 4. congenital malformation 5. patients with hemifacial microsomia 6. bone loss as a result of a mucormycotic infection or black fungus Exclusion Criteria: 1. acute stage oncology patients 2. There is not enough soft tissue to cover the facial implants

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
3D printed polyether ether ketone facial implants in repairing maxillofacial deformities
All patients underwent Computed Tomography (CT) scans under the condition of providing a large number of slices (more than 200 slices) per axis, and the thickness of each slice is less than 1 mm with 64-bit resolution, Then the design of the required facial implant was carried out in coordination between the designer and the surgical team. The final form of the facial implant was printed from PolyEther Ether Ketone (PEEK), and then surgical work was performed for patients under general anaesthetic according to the appropriate surgical entrance. The implants were fixed in place using titanium screws

Locations

Country Name City State
Syrian Arab Republic Tishreen university Latakia

Sponsors (1)

Lead Sponsor Collaborator
Tishreen University

Country where clinical trial is conducted

Syrian Arab Republic, 

References & Publications (3)

Dua R, Rashad Z, Spears J, Dunn G, Maxwell M. Applications of 3D-Printed PEEK via Fused Filament Fabrication: A Systematic Review. Polymers (Basel). 2021 Nov 22;13(22). pii: 4046. doi: 10.3390/polym13224046. Review. — View Citation

Kang J, Zhang J, Zheng J, Wang L, Li D, Liu S. 3D-printed PEEK implant for mandibular defects repair - a new method. J Mech Behav Biomed Mater. 2021 Apr;116:104335. doi: 10.1016/j.jmbbm.2021.104335. Epub 2021 Jan 21. — View Citation

Panayotov IV, Orti V, Cuisinier F, Yachouh J. Polyetheretherketone (PEEK) for medical applications. J Mater Sci Mater Med. 2016 Jul;27(7):118. doi: 10.1007/s10856-016-5731-4. Epub 2016 Jun 3. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of Cosmetic patients' satisfaction level . Three months after the surgery, we asked the patient to evaluate the aesthetic result by choosing a number from 1 to 5 , as 5 is the best cosmetic result.
satisfaction scale :
bad
medium
neutral
satisfied
very satisfied
after 3 months of the surgical procedure
Primary Evaluation of infection after using 3D printed polyetheretherketone facial implants in repair of maxillofacial deformities A doctor _not included in the research team_ performed clinical examinations of patients after surgical procedure a week, one month and three months to check for clinical signs of infection .
When there are signs of infection, he records the number 1 .
When there are no signs of infection, he records the number 0 .
after surgical procedure a week, one month and three months
See also
  Status Clinical Trial Phase
Completed NCT03387696 - Mucormycosis in ICU
Recruiting NCT04744454 - Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
Completed NCT00419770 - The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study Phase 2
Recruiting NCT05925660 - Mucorales PCR Screening in At-risk Hematology Patients N/A
Completed NCT04935463 - Mucormycosis in COVID-19
Completed NCT04550936 - Patterns of Real-World Isavuconazole Use - a Study of Patients With Mucormycosis or Invasive Aspergillosis
Completed NCT05074043 - COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
Not yet recruiting NCT05406037 - Biomarkers for Invasive Mucormycosis
Not yet recruiting NCT06440915 - Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children N/A
Completed NCT02845934 - Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis N/A
Completed NCT05212961 - COVID-19 and Rhino-orbital Mucormycosis
Recruiting NCT05097664 - Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran